Velardi, Enrico
Tsai, Jennifer J
Radtke, Stefan http://orcid.org/0000-0002-2842-4820
Cooper, Kirsten
Argyropoulos, Kimon V
Jae-Hung, Shieh
Young, Lauren F
Lazrak, Amina
Smith, Odette M
Lieberman, Sophie
Kreines, Fabiana
Shono, Yusuke
Wertheimer, Tobias
Jenq, Robert R
Hanash, Alan M http://orcid.org/0000-0002-3273-3634
Narayan, Prema
Lei, Zhenmin
Moore, Malcolm A
Kiem, Hans-Peter
van den Brink, Marcel R M
Dudakov, Jarrod A http://orcid.org/0000-0001-6220-5632
Article History
Received: 21 July 2016
Accepted: 13 December 2017
First Online: 8 January 2018
Change Date: 22 January 2018
Change Type: Corrigendum
Change Details: In the version of this article initially published online, the phrase "ex vitro" appears in the abstract. This should be "ex vivo". The error has been corrected in the print, PDF and HTML versions of this article.
Competing interests
: A provisional patent application has been filed on the use of LHRH-Ant as a treatment for hematopoietic recovery from radiation injury (US 15/033,178), with E.V., J.A.D., and M.R.M.v.d.B. listed as inventors. A provisional patent application has been filed on the use of LH to create, ablate, and modify primitive stem cell populations (US 62/566,897), with E.V., J.A.D., S.R., H.-P.K., and M.R.M.v.d.B. listed as inventors.